Table 4.

Cellular composition of Acute myeloid leukemia (AML) and healthy samples.

	Cell Type	Average of Cells in WB/PBMCs (%)	Range of Cells in WB/PBMCS (%)
AML	Leukemic blasts *	46.2/45.3	8.0–81.0/8.0–93.0
	CD3+T cells	9.9/6.3	1.5–23.3/0.4–24.0
	CD19+B cells	2.8/2.4	0.1–8.4/0.2–7.6
	CD56+CD3-NK-cells	4.8/1.9	0.4–9.8/0.2–6.3
	CD14+monocytes	3.4/1.8	0.1–11.5/0.1–5.7
Heathy	CD14+monocytes	5.6/7.0	4.4–8.5/2.6–12.7
	CD3+T cells	19.4/36.3	13.6–26.3/21.1–46.7
	CD56+CD3-NK-cells	3.4/4.8	2.3–6.9/3.5–6.6
	CD19+B cells	2.3/6.0	0.8–4.8/1.7–11.8

* expression of CD15⁺, CD33⁺, CD34⁺, CD65⁺ and/or CD117⁺; AML acute myeloid leukemia; WB whole blood; PBMCs peripheral blood mononuclear cells.